SCHEMBL355988

SCHEMBL355988

C=C[C@@H](O)COCCCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 2/20 0.46
HTT P42858 1/20 0.44
TSHR P16473 2/20 0.41
SPHK1 Q9NYA1 1/20 0.41
HSD17B10 Q99714 1/20 0.40
HPGD P15428 1/20 0.39
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C19 P33261 1/20 0.39
PLA2G2C Q5R387 1/20 0.39
LPAR5 Q9H1C0 4/20 0.39
LPAR1 Q92633 4/20 0.35
LPAR2 Q9HBW0 4/20 0.35
LPAR3 Q9UBY5 4/20 0.35
LPAR6 P43657 3/20 0.35
LPAR4 Q99677 3/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
ALOX15 P16050 1/20 0.35
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4948086 1.00 USP2 (0.46) USP2HTTTSHRSPHK1HSD17B10
SCHEMBL9187817 0.96 TSHR (0.43) USP2HTTTSHRSPHK1HSD17B10
SCHEMBL133349 0.94 USP2 (0.53) USP2HTTSPHK1CYP3A4CYP1A2
SCHEMBL9679064 0.92 USP2 (0.56) USP2HTTSPHK1CYP3A4CYP1A2
SCHEMBL13497248 0.82 SPHK1 (0.47) USP2HTTTSHRSPHK1HSD17B10
SCHEMBL10636655 0.82 TSHR (0.45) USP2HTTTSHRSPHK1HPGD
SCHEMBL11952634 0.79 SPHK1 (0.49) USP2HTTTSHRSPHK1HSD17B10
SCHEMBL11952635 0.79 SPHK1 (0.49) USP2HTTTSHRSPHK1HSD17B10
SCHEMBL15255391 0.79 SPHK1 (0.49) USP2HTTTSHRSPHK1HSD17B10
SCHEMBL15255390 0.79 SPHK1 (0.49) USP2HTTTSHRSPHK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8158790-B2 Cyclic amine compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-04-17 US disclosed
EP-2036896-B1 CYCLIC AMINE COMPOUND DAIICHI SANKYO CO LTD (JP) 2012-03-14 EP disclosed
US-20090286807-A1 CYCLIC AMINE COMPOUND DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-11-19 US disclosed
EP-2036896-A1 CYCLIC AMINE COMPOUND Daiichi Sankyo Company, Limited (JP) 2009-03-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286807-A1 CYCLIC AMINE COMPOUND HRH3, HRH4, H1-0 USP2 3753/4885HTT 635/4885TSHR 435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.